Acrobiosystems Co.,Ltd. (SHE:301080)
China
· Delayed Price · Currency is CNY 43.63
-1.37 (-3.04%)
At close: Mar 9, 2026
Acrobiosystems Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Operating Revenue | 782.44 | 632.94 | 532.8 | 466.58 | 376.71 | 239.78 | Upgrade
|
| Other Revenue | 12.09 | 12.09 | 10.85 | 7.85 | 8.28 | 6.54 | Upgrade
|
| Revenue | 794.52 | 645.02 | 543.65 | 474.43 | 384.99 | 246.32 | Upgrade
|
| Revenue Growth (YoY) | 33.63% | 18.65% | 14.59% | 23.23% | 56.30% | 138.47% | Upgrade
|
| Cost of Revenue | 111.78 | 98.24 | 85.14 | 59.01 | 34.27 | 22.96 | Upgrade
|
| Gross Profit | 682.74 | 546.78 | 458.52 | 415.42 | 350.72 | 223.35 | Upgrade
|
| Selling, General & Admin | 363 | 321.28 | 254.64 | 185.23 | 115.81 | 55.83 | Upgrade
|
| Research & Development | 175.55 | 161.87 | 122.22 | 112.47 | 59.55 | 30.65 | Upgrade
|
| Other Operating Expenses | 2.71 | 2.68 | 2.3 | 0.8 | 0.73 | 0.44 | Upgrade
|
| Operating Expenses | 544.62 | 487.3 | 379.85 | 299.12 | 177.09 | 87.72 | Upgrade
|
| Operating Income | 138.12 | 59.48 | 78.67 | 116.3 | 173.63 | 135.64 | Upgrade
|
| Interest Expense | -5.45 | -3.54 | -2.7 | -2.95 | -1.15 | - | Upgrade
|
| Interest & Investment Income | 57.17 | 61.91 | 60.92 | 63.25 | 10.72 | 0.8 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.56 | 3.56 | 10.87 | 15.5 | 1.42 | -2.27 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.11 | -2.82 | -2.78 | -1.72 | -1.06 | -1.15 | Upgrade
|
| EBT Excluding Unusual Items | 195.5 | 118.58 | 144.99 | 190.39 | 183.56 | 133.02 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.44 | -1.48 | 0.66 | 0.62 | 0.06 | 0.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.3 | -0.35 | - | 0.21 | 0.28 | -0.01 | Upgrade
|
| Asset Writedown | -21.16 | -0 | -0.11 | -0.76 | -0.05 | -0 | Upgrade
|
| Other Unusual Items | 8.16 | 8.16 | 15.12 | 24.52 | 11.59 | 0.61 | Upgrade
|
| Pretax Income | 183.25 | 124.91 | 160.67 | 214.99 | 195.44 | 133.63 | Upgrade
|
| Income Tax Expense | 10.54 | 4.87 | 13.12 | 15.77 | 22 | 17.94 | Upgrade
|
| Earnings From Continuing Operations | 172.71 | 120.04 | 147.55 | 199.21 | 173.44 | 115.69 | Upgrade
|
| Minority Interest in Earnings | 0.06 | 3.79 | 6.04 | 4.52 | 0.78 | 0.19 | Upgrade
|
| Net Income | 172.77 | 123.83 | 153.59 | 203.73 | 174.21 | 115.88 | Upgrade
|
| Net Income to Common | 172.77 | 123.83 | 153.59 | 203.73 | 174.21 | 115.88 | Upgrade
|
| Net Income Growth | 58.61% | -19.38% | -24.61% | 16.95% | 50.34% | 943.79% | Upgrade
|
| Shares Outstanding (Basic) | 168 | 168 | 168 | 168 | 133 | 126 | Upgrade
|
| Shares Outstanding (Diluted) | 168 | 168 | 168 | 168 | 133 | 126 | Upgrade
|
| Shares Change (YoY) | 0.12% | 0.02% | -0.04% | 26.35% | 5.55% | 394.52% | Upgrade
|
| EPS (Basic) | 1.03 | 0.74 | 0.91 | 1.21 | 1.31 | 0.92 | Upgrade
|
| EPS (Diluted) | 1.03 | 0.74 | 0.91 | 1.21 | 1.31 | 0.92 | Upgrade
|
| EPS Growth | 58.42% | -19.39% | -24.58% | -7.44% | 42.43% | 111.07% | Upgrade
|
| Free Cash Flow | 15.89 | -82.56 | -17.49 | -82.1 | 76.31 | 81.52 | Upgrade
|
| Free Cash Flow Per Share | 0.10 | -0.49 | -0.10 | -0.49 | 0.57 | 0.65 | Upgrade
|
| Dividend Per Share | 0.286 | 0.500 | 0.643 | 0.714 | 0.714 | - | Upgrade
|
| Dividend Growth | -66.67% | -22.23% | -10.00% | - | - | - | Upgrade
|
| Gross Margin | 85.93% | 84.77% | 84.34% | 87.56% | 91.10% | 90.68% | Upgrade
|
| Operating Margin | 17.38% | 9.22% | 14.47% | 24.51% | 45.10% | 55.07% | Upgrade
|
| Profit Margin | 21.75% | 19.20% | 28.25% | 42.94% | 45.25% | 47.05% | Upgrade
|
| Free Cash Flow Margin | 2.00% | -12.80% | -3.22% | -17.30% | 19.82% | 33.09% | Upgrade
|
| EBITDA | 172.33 | 88.28 | 100.27 | 131.94 | 182.24 | 141.28 | Upgrade
|
| EBITDA Margin | 21.69% | 13.69% | 18.44% | 27.81% | 47.34% | 57.36% | Upgrade
|
| D&A For EBITDA | 34.22 | 28.81 | 21.6 | 15.64 | 8.61 | 5.64 | Upgrade
|
| EBIT | 138.12 | 59.48 | 78.67 | 116.3 | 173.63 | 135.64 | Upgrade
|
| EBIT Margin | 17.38% | 9.22% | 14.47% | 24.51% | 45.10% | 55.07% | Upgrade
|
| Effective Tax Rate | 5.75% | 3.90% | 8.16% | 7.34% | 11.26% | 13.42% | Upgrade
|
| Revenue as Reported | 794.52 | 645.02 | 543.65 | 474.43 | 384.99 | 246.32 | Upgrade
|
| Advertising Expenses | - | 53.69 | 52 | 35.84 | 32.85 | 13.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.